Racial and Ethnic Disparities in Implantable Cardioverter-Defibrillator Utilization: A Contemporary Review

Tarryn Tertulien1, Kelvin Bush2, Larry R Jackson3

  • 1Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Insights

Racial disparities exist in implantable cardioverter-defibrillator (ICD) use for sudden cardiac death prevention. Addressing patient, provider, and system-level barriers is crucial for equitable access to life-saving ICD therapy.

Area of Science:

  • Cardiology
  • Health Disparities Research
  • Public Health

Background:

  • Sudden cardiac arrest (SCA) carries significant morbidity and mortality.
  • Racially minoritized populations experience a disproportionate burden of sudden cardiac death (SCD).
  • Eligible racially minoritized patients have lower rates of implantable cardioverter-defibrillator (ICD) therapy for SCD prevention.

Purpose of the Study:

  • To review racial and ethnic disparities in ICD utilization.
  • To identify barriers to ICD care for racially minoritized patients.
  • To propose interventions for equitable ICD uptake.

Main Methods:

  • Literature review of studies examining ICD utilization across racial and ethnic groups.
  • Analysis of patient, provider, health system, and societal factors contributing to disparities.
  • Synthesis of proposed interventions to improve equitable access to ICD therapy.

Main Results:

  • Racially minoritized populations are disproportionately eligible for ICD therapy but receive it less frequently.
  • Barriers include reduced access to cardiac specialists, less counseling on ICDs, and lower implantation rates.
  • Disparities are multifactorial, stemming from patient, provider, health system, and societal influences.

Conclusions:

  • Racial and ethnic disparities in ICD use for SCD prevention are well-documented.
  • Interventions must focus on equitable care delivery, increased diversity in trials and workforce, and addressing historical injustices.
  • Prioritizing access for racially minoritized patients is essential for reducing SCD mortality.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...